ArticleFrontiers in neuroinformatics2025
Large-scale EM data reveals myelinated axonal changes and altered connectivity in the corpus callosum of an autism mouse model.
Article in Frontiers in neuroinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- MyelinASN neuro · 2026Article
- Can optic nerve morphology in children with autism spectrum disorder be associated with atypical visual-sensory behaviors?Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Autism spectrum disorder (ASD) encompasses a diverse range of neurodevelopmental disorders with complex etiologies, including genetic, environmental, and neuroanatomical factors. While the exact mechanisms underlying ASD remain unclear, structural abnormalities in the brain offer valuable insights into its pathophysiology. The corpus callosum, the largest white matter tract in the brain, plays a crucial role in interhemispheric communication, and its structural abnormalities may contribute to ASD-related phenotypes. Methods: To investigate the ultrastructural alterations in the corpus callosum associated with ASD, we utilized serial scanning electron microscopy (sSEM) in mice. A dataset of the entire sagittal sections of the corpus callosum from wild-type and Shank3B mutant mice was acquired at 4 nm resolution, enabling precise comparisons of myelinated axon properties. Leveraging a fine-tuned EM-SAM model for automated segmentation, we quantitatively analyzed key metrics, including G-ratio, myelin thickness, and axonal density. Results: In the corpus callosum of Shank3B autism model mouse, we observed a significant increase in myelinated axon density, accompanied by thinner myelin sheaths compared to wild-type. Additionally, we identified abnormalities in the diameter distribution of myelinated axons and deviations in G-ratio. Notably, these ultrastructural alterations were widespread across the corpus callosum, suggesting a global disruption of myelinated axon integrity. Discussion: This study provides novel insights into the microstructural abnormalities of the corpus callosum in ASD mouse, supporting the hypothesis that myelination deficits contribute to ASD-related communication impairments between brain hemispheres. However, given the structural focus of this study, further research integrating functional assessments is necessary to establish a direct link between these morphological changes and ASD-related neural dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.